John R. Stuelpnagel - Nov 16, 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Stock symbol
TXG
Transactions as of
Nov 16, 2021
Transactions value $
-$794,166
Form type
4
Date filed
11/18/2021, 06:47 PM
Previous filing
Nov 3, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale -$126K -800 -0.22% $157.55 356K Nov 16, 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale -$485K -3.05K -0.86% $158.79 353K Nov 16, 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale -$167K -1.05K -0.3% $159.80 352K Nov 16, 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale -$16K -100 -0.03% $160.32 352K Nov 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $157.02 to $157.845. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $158.19 to $159.15. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $159.23 to $160.17. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.